Detection of Hurthle cell carcinoma using sestamibi

Thyroid

Volumn 18, Issue 5, 2008, Pages 575-576

  Chamnanrabiabkij, Ekaphum ^a   Welch, Andy ^a   Jayapaul, Muthu K ^a   Perros, Petros ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; VITAMIN D;

AGED; ARTICLE; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CASE REPORT; DRUG UPTAKE; ECHOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; HURTHLE CELL CARCINOMA; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOCALCEMIA; ONCOCYTOMA; PRIORITY JOURNAL; THYROID NODULE; THYROIDECTOMY;

ADENOMA, OXYPHILIC; AGED; FEMALE; HUMANS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 43449090098     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2007.0200     Document Type: Article

References (3)

1. Palestro C, Tomas M, Tronco G 2005 Radionuclide imaging of the parathyroid glands. Semin Nucl Med 35:266-276.
2. Schillaci O, Spanu A, Madeddu G 2005 [99mTc]Sestamibi and [99mTc]tetrofosmin in oncology: SPET and fusion imaging in lung cancer, malignant lymphomas and brain tumors. Q J Nucl Med Mol Imaging 49:133-144.
3. Boi F, Lai ML, Deias C, Piga M, Serra A, Uccheddu A, Faa G, Mariotti S 2003 The usefulness of 99mTc-SestaMIBI scan in the diagnostic evaluation of thyroid nodules with oncocytic cytology. Eur J Endocrinol 149:493-498.